Ever since I wrote this [off to juvey…]: I’m lead to two conclusions. First, in our negotiations with the pharmaceutical industry [and the KOLs], I’m closer to scorched earth than on any other issue I can think of. I’m not a scorched-earth kind of guy, but it’s clear that no matter what they say or […]
Change, Challenge, and Opportunity: Psychiatry Through the Looking Glass of Research PsychiatricNews From the President by Steven Hyman, M.D. and Jeffrey Lieberman, M.D. October 17, 2013 The first two articles in this series addressed the prospect of change in psychiatric medicine and mental health care and the anticipated effects, in this regard, of health care […]
Almost two years ago, I went to Austin Texas for the Allen Jones and the State of Texas v. Janssen Trial. At that time, I’d been writing about the psychopharmaceutical industry and its alliances with academic psychiatry for a couple of years, and I’d corresponded some with Allen Jones – the whistle-blower who exposed the […]
I spent a childhood being groomed for science. That’s what the 1950s were about and all the vectors pointed that way. But there was a private bent towards history in there somewhere that never got around to flowering. As an adult doctor, it was the histories of my patients [and myself] that finally brought it […]
Johnson & Johnson, Risperdal And A Lack Of Clinical Trial Disclosure Pharmalot by Ed Silverman 11/05/2013 In the wake of the $2.2 billion settlement that Johnson & Johnson will pay to resolve both criminal and civil charges leveled by US authorities has focused attention on off-label marketing practices and kickbacks paid to physicians and a […]
The 1980 DSM-III Revolution made it to my life around 1984 with the coming of a new chairman to my department. All he talked about was research. It took me a while to figure out that meant drug research. But from the start, he also talked a lot about PET [Positron Emission Tomography], a technique […]
We are the hollow men We are the stuffed men Leaning together Headpiece filled with straw. Alas!… T.S. Eliot 1925 Eliot’s Hollow Men expressing his disillusionment with the Europe between the World Wars seems to me a fitting description for the period we’re in with matters psychopharmacologic and psychiatric right now. We’ve been through a […]
GSK’s Chinese executives, but not company, likely to face charges in China: sources Reuters By Adam Jourdan November 4, 2013 SHANGHAI [Reuters] – Chinese police investigating allegations of widespread corrupt practices at GlaxoSmithKline Plc [GSK] are likely to charge some of its Chinese executives but not the British drugmaker itself, legal and industry sources said. […]
Emil Kraepelin‘s term, Dementia Praecox, literally means a markedly abnormal mental state that came on in young adulthood, usually progressing to an early death. He thought it was a deteriorating brain disease. Eugen Bleuler later wrote about the cases in greater detail – noting that many cases recovered and left the hospital. He described "the […]
When I asked Sandra Steingard to post here, I had little worry that we would disagree about much of anything after reading her posts on Mad in America. In a guest post from Sandy Steingard…, she calls herself muddled three times. In the face of the complexity of the narratives patients bring to us mental […]